4-aminomethyl-1-(ethoxycarbonyl)-4-(2-methylphenyl)piperidine | 363172-75-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-aminomethyl-1-(ethoxycarbonyl)-4-(2-methylphenyl)piperidine
• 英文别名: ethyl 4-(aminomethyl)-4-(2-methylphenyl)piperidine-1-carboxylate
• CAS: 363172-75-2
• 化学式: C₁₆H₂₄N₂O₂
• 分子量: 276.379
• InChiKey: MQVJBAXCLROSCM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  55.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-aminomethyl-1-(ethoxycarbonyl)-4-(2-methylphenyl)piperidine 、 氯甲酸乙酯 在 三乙胺 作用下， 以 二氯甲烷 、 水 为溶剂， 以51%的产率得到1-(Ethoxycarbonyl)-4-(ethoxycarbonyl Aminomethyl)-4-(2-methylphenyl)piperidine
  参考文献：
  名称：

  Diphenylalkylamine derivatives useful as opioid receptor agonists

  摘要：

  一种具有与阿片受体δ亲和力的物质，其由以下一般公式（I）表示：其中，X代表一般公式的一个基团：—CO—N（R5）（R6）（II）等，n代表1至3，R1和R2代表氢原子、卤素原子、低碳烷基团等，R3代表氢原子、卤素原子、低碳烷基团等，R4代表饱和或不饱和的单环或双环碳环基团等，R5到R12代表氢原子、低碳烷基团等，R3和R4、R5和R6、R7或R8和R9以及R10可能相互结合形成环状结构，并且包括该物质作为活性成分的用于预防和/或治疗中枢神经系统疾病和外周神经系统疾病的药物。

  公开号：

  US20030176693A1
• 作为产物：
  描述：

  4-Cyano-1-(ethoxycarbonyl)-4-(2-methylphenyl)piperidine 在 palladium-carbon 盐酸 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 生成 4-aminomethyl-1-(ethoxycarbonyl)-4-(2-methylphenyl)piperidine
  参考文献：
  名称：

  Diphenylalkylamine derivatives useful as opioid receptor agonists

  摘要：

  一种具有与阿片受体δ亲和力的物质，其由以下一般公式（I）表示：其中，X代表一般公式的一个基团：—CO—N（R5）（R6）（II）等，n代表1至3，R1和R2代表氢原子、卤素原子、低碳烷基团等，R3代表氢原子、卤素原子、低碳烷基团等，R4代表饱和或不饱和的单环或双环碳环基团等，R5到R12代表氢原子、低碳烷基团等，R3和R4、R5和R6、R7或R8和R9以及R10可能相互结合形成环状结构，并且包括该物质作为活性成分的用于预防和/或治疗中枢神经系统疾病和外周神经系统疾病的药物。

  公开号：

  US20030176693A1

文献信息

• Phenoxyalkylamine derivatives useful as opioid receptor agonists
  申请人：——

  公开号：US20030171370A1

  公开（公告）日：2003-09-11

  A medicament useful for preventive and/or therapeutic treatment of nerve system diseases which comprises, as an active ingredient, a compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof: 1 wherein, X represents a group represented by the following general formula (II), (III), (IV), (V), or (VI), 2 “A” represents a saturated or unsaturated 3- to 6-membered carbocyclic group and the like, “B” represents CH 2 and the like, “n” represents 0 to 2, R 1 represents a hydrogen atom, a halogen atom and the like, R 2 , R 3 , and R 7 to R 14 represent a hydrogen atom, a lower alkyl group which may be substituted and the like, R 4 represents a hydrogen atom, a lower alkyl group which may be substituted and the like, R 5 represents a hydrogen atom, a halogen atom and the like, R 6 represents a saturated or unsaturated monocyclic or bicyclic carbocyclic group and the like, and R 5 and R 6 , R 7 and R 8 , R 9 and R 10 , or R 11 and R 12 may bind to each other to form a cyclic structure.

  一种用于预防和/或治疗神经系统疾病的药物，其活性成分为以下通用式（I）或其药理学可接受的盐所代表的化合物： 其中，X代表以下通用式（II）、（III）、（IV）、（V）或（VI）所代表的基团，“A”代表饱和或不饱和的3-至6-成员碳环基团等，“B”代表CH2等，“n”代表0至2，R1代表氢原子、卤素原子等，R2、R3和R7至R14代表氢原子、可能被取代的较低烷基基团等，R4代表氢原子、可能被取代的较低烷基基团等，R5代表氢原子、卤素原子等，R6代表饱和或不饱和的单环或双环碳环基团等，且R5和R6、R7和R8、R9和R10，或R11和R12可以结合在一起形成环状结构。
• Phenoxyalkylamine derivatives useful as opioid delta receptor ligands
  申请人：Tsushima Masaki

  公开号：US20050148583A1

  公开（公告）日：2005-07-07

  A medicament useful for preventive and/or therapeutic treatment of nerve system diseases which comprises, as an active ingredient, a compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof: wherein, X represents a group represented by the following general formula (II), (III), (IV), (V), or (VI), “A” represents a saturated or unsaturated 3- to 6-membered carbocyclic group and the like, “B” represents CH 2 and the like, “n” represents 0 to 2, R 1 represents a hydrogen atom, a halogen atom and the like, R 2 , R 3 , and R 7 to R 14 represent a hydrogen atom, a lower alkyl group which may be substituted and the like, R 4 represents a hydrogen atom, a lower alkyl group which may be substituted and the like, R 5 represents a hydrogen atom, a halogen atom and the like, R 6 represents a saturated or unsaturated monocyclic or bicyclic carbocyclic group and the like, and R 5 and R 6 , R 7 and R 8 , R 9 and R 10 , or R 11 and R 12 may bind to each other to form a cyclic structure.

  一种用于神经系统疾病的预防和/或治疗的药物，其包括以下通式（I）所表示的化合物或其药学上可接受的盐作为活性成分： 其中，X代表以下通式（II），（III），（IV），（V）或（VI）所表示的基团，“A”代表饱和或不饱和的3-至6-成员的碳环基团等，“B”代表CH2等，“n”代表0至2，“R1”代表氢原子，卤原子等，“R2”，“R3”和“R7”至“R14”代表氢原子，可被取代的较低烷基基团等，“R4”代表氢原子，可被取代的较低烷基基团等，“R5”代表氢原子，卤原子等，“R6”代表饱和或不饱和的单环或双环碳环基团等，“R5”和“R6”，“R7”和“R8”，“R9”和“R10”，或“R11”和“R12”可以结合在一起形成环状结构。
• Phenoxyalkylamine derivatives useful as opioid δ receptor agonists
  申请人：Tsushima Masaki

  公开号：US06916822B2

  公开（公告）日：2005-07-12

  A medicament useful for preventive and/or therapeutic treatment of nerve system diseases which comprises, as an active ingredient, a compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof: wherein, X represents a group represented by the following general formula (II), (III), (IV), (V), or (VI), “A” represents a saturated or unsaturated 3- to 6-membered carbocyclic group and the like, “B” represents CH 2 and the like, “n” represents 0 to 2, R 1 represents a hydrogen atom, a halogen atom and the like, R 2 , R 3 , and R 7 to R 14 represent a hydrogen atom, a lower alkyl group which may be substituted and the like, R 4 represents a hydrogen atom, a lower alkyl group which may be substituted and the like, R 5 represents a hydrogen atom, a halogen atom and the like, R 6 represents a saturated or unsaturated monocyclic or bicyclic carbocyclic group and the like, and R 5 and R 6 , R 7 and R 8 , R 9 and R 10 , or R 11 and R 12 may bind to each other to form a cyclic structure.

  一种用于预防和/或治疗神经系统疾病的药物，其包含以下通式（I）或其药学上可接受的盐作为活性成分的化合物： 其中，X表示以下通式（II）、（III）、（IV）、（V）或（VI）表示的基团，“A”表示饱和或不饱和的3-至6-成员的碳环基团等，“B”表示CH2等，“n”表示0至2，R1表示氢原子、卤原子等，R2、R3和R7至R14表示氢原子、可被取代的较低烷基基团等，R4表示氢原子、可被取代的较低烷基基团等，R5表示氢原子、卤原子等，R6表示饱和或不饱和的单环或双环碳环基团等，并且R5和R6、R7和R8、R9和R10或R11和R12可以结合在一起形成环状结构。
• DIPHENYLALKYLAMINE DERIVATIVES USEFUL AS OPIOID DELTA RECEPTOR AGONISTS
  申请人：Meiji Seika Kaisha, Ltd.

  公开号：EP1277737A1

  公开（公告）日：2003-01-22

  A substance having affinity for an opioid δ receptor, which is represented by the following general formula (I): wherein, X represents a group of the general formula: -CO-N(R5)(R6) (II) and the like, n represents 1 to 3, R1 and R2 represent a hydrogen atom, a halogen atom, a lower alkyl group and the like, R3 represents a hydrogen atom, a halogen atom, a lower alkyl group and the like, R4 represents a saturated or unsaturated monocyclic or bicyclic carbocyclic group and the like, R5 to R12 represent a hydrogen atom, a lower alkyl group and the like, and R3 and R4, R5 and R6, R7 or R8 and R9 and R10 may bind to each other to form a cyclic structure, and a medicament useful for preventive and/or therapeutic treatment of central nervous system diseases and peripheral nervous system diseases comprising the substance as an active ingredient.

  一种对阿片δ受体具有亲和力的物质，由以下通式(I)表示： 其中，X 代表通式中的基团：-R1 和 R2 代表氢原子、卤素原子、低级烷基等，R3 代表氢原子、卤素原子、低级烷基等，R4 代表饱和或不饱和的单环或双环碳环基团等，R5 至 R12 代表氢原子、低级烷基等、R3和R4、R5和R6、R7或R8以及R9和R10可以相互结合形成环状结构，以及一种用于预防和/或治疗中枢神经系统疾病和周围神经系统疾病的药物，该药物包含该物质作为活性成分。
• PHENOXYALKYLAMINE DERIVATIVES USEFUL AS OPIOID DELTA RECEPTOR AGONISTS
  申请人：Meiji Seika Kaisha, Ltd.

  公开号：EP1256575B1

  公开（公告）日：2005-08-17